Skip to content
← Back to this collection

PUBLICATIONS · 24497539

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2014 Mar 27
First author
Pulsipher MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pulsipher MA
      type
      Author
    2. name
      Langholz B
      type
      Author
    3. name
      Wall DA
      type
      Author
    4. name
      Schultz KR
      type
      Author
    5. name
      Bunin N
      type
      Author
    6. name
      Carroll WL
      type
      Author
    7. name
      Raetz E
      type
      Author
    8. name
      Gardner S
      type
      Author
    9. name
      Gastier-Foster JM
      type
      Author
    10. name
      Howrie D
      type
      Author
    11. name
      Goyal RK
      type
      Author
    12. name
      Douglas JG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pulsipher MA
      type
      Author
    2. name
      Langholz B
      type
      Author
    3. name
      Wall DA
      type
      Author
    4. name
      Schultz KR
      type
      Author
    5. name
      Bunin N
      type
      Author
    6. name
      Carroll WL
      type
      Author
    7. name
      Raetz E
      type
      Author
    8. name
      Gardner S
      type
      Author
    9. name
      Gastier-Foster JM
      type
      Author
    10. name
      Howrie D
      type
      Author
    11. name
      Goyal RK
      type
      Author
    12. name
      Douglas JG
      type
      Author
    bibliography ids
    1. nci-bib-e796fe20713ec6f7870b5f56
    book metadata
    content sha256
    a0f3f24887e1097f63cff5a3fe7c6d0829ae3b8bc077c50435a9db9920ad6855
    document type
    citation
    dois
    1. 10.1182/blood-2013-10-534297
    electronic publication date
    display
    2014 Feb 4
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24497539
    immutable id
    pubmed:24497539@a0f3f24887e1097f63cff5a3fe7c6d0829ae3b8bc077c50435a9db9920ad6855
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    13
    name
    Blood
    nlm unique id
    7603509
    pages
    2017-25
    volume
    123
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24497539
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      c6533d45345f035a75fd428b9e1cac843bdf7ce12fb00587779d8c98a4770d14
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Mar 27
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24497539/
      title
      The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.

      Preserved source evidence · Not medical advice